Treatment of choroidal neovascularisation in highly myopic eyes;Zdravljenje horoidalne neovaskularizacije pri visoko kratkovidnih očeh

Zdravniski Vestnik

Volumn 81, Issue SUPPL., 2012, Pages 67-

  Lavrič, Alenka ^a   Urbančič, Mojca ^a   Kraut, Aleksandra ^a   Sevšek, Davorin ^a   Mekjavić, Polona Jaki ^a  

^a Univerzitetni klinični center Ljubljana ^*  (Slovenia)

Author keywords

Anti VEG F therapy; Choroidal neovascularisation; High myopia; Photodynamic therapy

Indexed keywords

VASCULOTROPIN INHIBITOR; VERTEPORFIN;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CLINICAL EFFECTIVENESS; DRUG EFFICACY; FEMALE; HIGH MYOPIA; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PHOTODYNAMIC THERAPY; RETROSPECTIVE STUDY; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84863933641     PISSN: 13180347     EISSN: 15810224     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Attebo K, Ivers RQ, Mitchell P. Refractive errors in an older population: the Blue Mountains Eye Study. Ophthalmology 1999; 106: 1066-1072.
2. Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 1991; 7: 403-422.
3. Wong TY, Foster PJ, Hee J, Ng TP, Tielsch JM, Chew SJ et al. Prevalence and risk factors for refractive errors in adult Chinese in Singapore. Invest Ophthalmol Vis Sci 2000; 41: 2486-2494.
4. Cohen SY, Laroche A, Leguen Y, Soubrane G, Coscas GJ. Etiology of choroidal neovascularization in young patients. Ophthalmology 1996; 103(8): 1241-1244.
5. Ohno-Matsui K, Yoshida T, Futagami S, Yasuzumi K, Shimada N, Kojima A et al. Patchy atrophy and lacquer cracks predispose to the development of choroidal neovascularization in pathological myopia. Br J Ophthalmol 2003; 87: 570-573.
6. Ohno-Matusi K, Yoshida T. Myopic choroidal neovascularization: natural course and treatment. Curr Opin Ophthalmol 2004; 15(3): 197-202.
7. Yoshida T, Ohno-Matsui K, Yasuzumi K, Kojima A, Shimada N, Futagami S et al. Myopic choroidal neovascularization: a 10-year follow-up. Ophthalmology 2003; 110(7): 1297-1305.
8. Ruiz-Moreno JM, Montero JA. Long-term visual acuity after argon green laser photocoagulation of juxtafoveal choroidal neovascularization in highly myopic eyes. Eur J Ophthalmol 2002; 12: 117-122.
9. Uemura A, Thomas M. Subretinal surgery for choroidal neovascularization in patients with high myopia. Arch Ophthalmol 2000; 118: 344-350.
10. Verteporfin in Photodynamic Therapy (VIP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial-VIP report no. 1. Ophthalmology 2001; 108: 841-852.
11. Marticorena J, Gomez-Ulla F, Fernandez M, Pazos B, Rodriguez-Cid MJ, Sanchez-Salorio M. Combined photodynamic therapy and intravitreal triamcinolone acetonide for the treatment of myopic subfoveal choroidal neovascularization. Am J Ophthalmol 2006; 142(2): 335-337.
12. Brancato R, Pece A, Avanza P, Radrizzani E. Photocoagulation scar expansion after laser therapy for choroidal neovascularisation in degenerative myopia. Retina 1990; 10(4): 239-243.
13. Blinder KJ, Blumenkranz MS, Bressler NM, Bressler SB, Donato G, Lewis H, et al. Verteporfirin therapy of subfoveal choroidal neovascularisation in pathologic myopia: 2-year results of randomized clinical trial-VIP report no.3. Ophthalmology 2003; 110(4): 667-673.
14. Okamoto N, Tobe T, Hackett SF, Ozaki H, Vinores MA, LaRochelle W et al. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol 1997; 151(1): 281-291.
15. Cohen SY. Anti-VEGF drugs as the 2009 first--line therapy for choroidal neovascularization in pathologic myopia. Retina 2009; 29(8): 1062-1066.
16. Fung AE, Lalwani GA, Rosenfeld PJ, Dubovy SR, Michels S, Feuer WJ et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 2007; 143(4): 566-583.
17. Kobayashi K, Mandai M, Suzuma I, Kobayashi H, Okinami S. Expression of estrogen receptor in the choroidal neovascular membranes in highly myopic eyes. Retina 2002; 22(4): 418-422.
18. Tanemura M, Miyamoto N, Mandai M, Kamizuru H, Ooto S, Yasukawa T et al. The role of estrogen and estrogen receptorbeta in choroidal neovascularization. Mol Vis 2004; 6; 10: 923-932.
19. Hampton GR, Kohen D, Bird AC. Visual prognosis of disciform degeneration in myopia. Ophthalmology 1983; 90(8): 923-926.
20. Lam DS, Chan WM, Liu DT, Fan DS, Ali WW, Chong KK. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up. Br J Ophthalmol 2004; 88(10): 1315-1319.
21. Gharbiya M, Giustolisi R, Allievi F, Fantozzi N, Mazzeo L, Scavella V, et al. Choroidal neovascularization in pathologic myopia: intravitreal ranibizumab versus bevacizumab-a randomized controlled trial. Am J Ophthalmol 2010; 149(3): 458-464.
22. Ruiz-Moreno JM, Montero JA, Arias L, Araiz J, Gomez-Ulla F, Silva R, et al. Twelve-month outcome after one intravitreal injection of bevacizumab to treat myopic choroidal neovascularization. Retina 2010; 30(10): 1609-1615.
23. Niwa Y, Sawada O, Miyake T, Kakinoki M, Sawada T, Kawamura H, et al. Comparison between One Injection and Three Monthly Injections of Intravitreal Bevacizumab for Myopic Choroidal Neovascularization. Ophthalmoc Res 2011; 47(3): 135-140.
24. Parodi MB, Da Pozzo S, Ravalico G. Retinal pigment epithelium changes after photodynamic therapy for choroidal neovascularization in pathological myopia. Acta Ophthalmol Scand 2007; 85(1): 50-54.
25. Yoon JU, Byun YJ, Koh HJ. Intravitreal anti-VEGF versus photodynamic therapy with verteporfin for treatment of myopic choroidal neovascularization. Retina 2010; 30(3): 418-424.
26. Pece A, Vadala M, Isola V, et al. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization in pathologic myopia: a long-term follow-up study. Am J Ophthalmol 2007; 143: 449-454